La mayora de estos medicamentos se administran mediante inyeccin subcutnea, con frecuencias que varan desde una vez al da hasta una vez por semana, dependiendo del frmaco especfico
88% reduced sugar cravings
These medications work directly on regions of the brain involved in appetite control, such as the hypothalamus, helping you feel fuller longer, reducing hunger sensations, and curbing cravings
Who should not use GLP-1 therapy
These medications carry a boxed warning about thyroid C-cell tumors (contraindicated with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) and warnings about potential risks including pancreatitis, gallbladder disease, acute kidney injury with dehydration, and worsening diabetic retinopathy with rapid glucose reduction (particularly with semaglutide)
Salpeter SR, Greyber E, Paternak GA et al